MX2022007795A - Proceso para la identificacion de consorcios de cepas probioticas adecuadas para la degradacion de gluten. - Google Patents

Proceso para la identificacion de consorcios de cepas probioticas adecuadas para la degradacion de gluten.

Info

Publication number
MX2022007795A
MX2022007795A MX2022007795A MX2022007795A MX2022007795A MX 2022007795 A MX2022007795 A MX 2022007795A MX 2022007795 A MX2022007795 A MX 2022007795A MX 2022007795 A MX2022007795 A MX 2022007795A MX 2022007795 A MX2022007795 A MX 2022007795A
Authority
MX
Mexico
Prior art keywords
consortia
identify
probiotic strains
strains suitable
gluten degradation
Prior art date
Application number
MX2022007795A
Other languages
English (en)
Inventor
Stefan Pelzer
Michael Schwarm
Bodo Speckmann
Marco Gobbetti
Cagno Raffaella Di
Thomas Berngruber
Original Assignee
Evonik Operations Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Operations Gmbh filed Critical Evonik Operations Gmbh
Publication of MX2022007795A publication Critical patent/MX2022007795A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a un proceso para la identificación de consorcios de cepas probióticas pertenecientes, por ejemplo, a los géneros Lactobacillus, Bacillus, Pediococcus y Weissella que se pueden usar en preparaciones para suplementos alimenticios, producción de alimentos y aplicaciones farmacéuticas con la intención de ejecutar una degradación rápida y segura del gluten a digestos no tóxicos y no inmunogénicos.
MX2022007795A 2019-12-23 2020-11-27 Proceso para la identificacion de consorcios de cepas probioticas adecuadas para la degradacion de gluten. MX2022007795A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19219257 2019-12-23
PCT/EP2020/083746 WO2021129997A1 (en) 2019-12-23 2020-11-27 Process to identify consortia of probiotic strains suitable for gluten degradation

Publications (1)

Publication Number Publication Date
MX2022007795A true MX2022007795A (es) 2022-10-18

Family

ID=69005543

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022007795A MX2022007795A (es) 2019-12-23 2020-11-27 Proceso para la identificacion de consorcios de cepas probioticas adecuadas para la degradacion de gluten.

Country Status (11)

Country Link
US (1) US20230042485A1 (es)
EP (1) EP4081631A1 (es)
JP (1) JP2023507203A (es)
KR (1) KR20220121845A (es)
CN (1) CN114867844A (es)
AR (1) AR120748A1 (es)
AU (1) AU2020412216A1 (es)
BR (1) BR112022012571A2 (es)
CA (1) CA3162327A1 (es)
MX (1) MX2022007795A (es)
WO (1) WO2021129997A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240099205A (ko) * 2021-10-26 2024-06-28 에보닉 오퍼레이션스 게엠베하 장내 미생물군집 조절을 위한 프로바이오틱 조성물
WO2024068302A1 (en) * 2022-09-30 2024-04-04 Evonik Operations Gmbh Probiotic composition for the treatment of malnutrition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130121976A1 (en) * 2010-03-12 2013-05-16 Agusti Montserrat Carreras Lactic Acid Bacteria for Coeliac Disease
CA2949321A1 (en) * 2014-05-23 2015-11-26 Consejo Superior De Investigaciones Cientificas (Csic) New strain of lactobacillus casei with ability to degrade the immunotoxic peptide from gluten
PE20200715A1 (es) * 2017-07-12 2020-06-30 Gonzalez De La Torre Javier Proceso de degradacion de gliadina para obtener una harina libre de gluten
CN114845571A (zh) * 2019-12-23 2022-08-02 赢创运营有限公司 用于麸质降解的包含至少一种芽孢杆菌属和乳杆菌属菌株的细菌聚生体

Also Published As

Publication number Publication date
CN114867844A (zh) 2022-08-05
KR20220121845A (ko) 2022-09-01
US20230042485A1 (en) 2023-02-09
AU2020412216A1 (en) 2022-08-18
JP2023507203A (ja) 2023-02-21
BR112022012571A2 (pt) 2022-09-06
CA3162327A1 (en) 2021-07-01
WO2021129997A1 (en) 2021-07-01
EP4081631A1 (en) 2022-11-02
AR120748A1 (es) 2022-03-16

Similar Documents

Publication Publication Date Title
PH12018500954A1 (en) Feed additive composition
MX2021000285A (es) Composiciones que comprenden cepas bacterianas.
MX2022007796A (es) Preparacion que comprende cepas probioticas para la degradacion del gluten.
UA115330C2 (uk) Біозахист із застосуванням штамів lactobacillus rhamnosus
MX351627B (es) Bioproteccion usando cepas de lactobacillus paracasei.
MX2022007795A (es) Proceso para la identificacion de consorcios de cepas probioticas adecuadas para la degradacion de gluten.
MX2018002093A (es) Composicion y metodo para el tratamiento y profilaxis de infeccion e inflamacion intestinal.
WO2020091179A3 (ko) 프로바이오틱스를 유효 성분으로 포함하는 이차성 골다공증의 예방 또는 치료용 조성물
MX2022007775A (es) Composición para usarse en terapia de microbiota.
AU2019263623A8 (en) Probiotic Bifidobacterium breve strain and compositions comprising said strain
PH12018550110A1 (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
MX2016014991A (es) Composiciones que contienen acido borico y una mezcla de lactobacilos.
WO2020091180A3 (ko) 프로바이오틱스를 유효 성분으로 포함하는 이차성 골다공증의 예방 또는 치료용 조성물
MY193458A (en) Microorganism for producing a mycosporine-like amino acid and method for producing a mycosporine-like amino acid using the same
EP4360625A3 (en) Prebiotic and probiotic treatment to reduce oral dysbiosis and promote eubiosis
CO2017007338A2 (es) Composición que comprende dos cepas de las especies microbianas lactobacillus rhamnosus y bifidobacterium longum capaces de incrementar la fertilidad masculina
MX2019005535A (es) Streptococcus thermophilus para uso en la preparación de productos fermentados.
MX2015010694A (es) Peptidos funcionales para trastornos de obesidad.
MX2021004150A (es) Composiciones que comprenden cepas bacterianas.
MX2018016277A (es) Composicion de panaderia mejorada.
MX2019000023A (es) Composicion.
KR20180084258A (ko) 계피추출물 및 유산균을 함유하는 면역 증강용 조성물
CA2913067C (fr) Utilisation d'une bacterie isolee du genre pseudoalteromonas, cyclolipopeptides et leurs utilisations
MX2020007906A (es) Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas.
WO2021252760A3 (en) Swine origin probiotics that promote health and growth performance in pigs